*Treatment of Chlamydial Infections DOI: http://dx.doi.org/10.5772/intechopen.109648*

[42] Rours IGIJG, Hammerschlag MR, Ott A, De Faber TJTHN, Verbrugh HA, de Groot R, et al. *Chlamydia trachomatis* as a cause of neonatal conjunctivitis in Dutch infants. Pediatrics. 2008;**121**(2): e321-e326

[43] Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports. 2021;**70**(4):1-187 [Internet] [cited 2022 Nov 28]. Available from: https://www.cdc. gov/mmwr/volumes/70/rr/rr7004a1.htm

[44] Zikic A, Schünemann H, Wi T, Lincetto O, Broutet N, Santesso N. Treatment of neonatal chlamydial conjunctivitis: A systematic review and meta-analysis. Journal of the Pediatric Infectious Diseases Society. 2018;**7**(3):e107-e115

[45] Niforatos JD, Rothman RE. Sexually transmitted infections treatment guidelines, 2021. Annals of Emergency Medicine. 2022;**80**(1):68-70

[46] Heggie AD. Topical Sulfacetamide vs Oral erythromycin for neonatal chlamydial conjunctivitis. Archives of Pediatrics & Adolescent Medicine. 1985;**139**(6):564 [Internet]. Available from: http://archpedi.jamanetwork. com/article.aspx?doi=10.1001/ archpedi.1985.02140080034027

[47] Hammerschlag MR. Chlamydial and gonococcal infections in infants and children. Clinical Infectious Diseases. 2011;**53**(suppl\_3):S99-S102 [Internet]. Available from: http://academic.oup. com/cid/article/53/suppl\_3/S99/312712/ Chlamydial-and-Gonococcal-Infectionsin-Infants

[48] Lee WJA, Chen CC. Adult inclusion conjunctivitis diagnosed by polymerase chain reaction and Giemsa stain. IDCases. Netherlands. 2022;**27**:e01367

[49] Sarıer M. Prevalence of Polymicrobial infection in urethritis. Journal of Urological Surgery. 2019;**6**(3):180-183

[50] Sarıer M, Duman İ, Göktaş Ş. Demirorcid.org M, Kukul E. results of multiplex polymerase chain reaction assay to identify urethritis pathogens. Journal of Urological Surgery. 2017;**4**(1):18-22

[51] Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports. 2014;**63**(RR-02):1-19

[52] Sarier M, Sepin N, Duman I, Demir M, Hizel A, Göktaş Ş, et al. Microscopy of gram-stained urethral smear in the diagnosis of urethritis: Which threshold value should be selected? Andrologia. 2018;**50**(10):1-4

[53] World Health Organization (WHO). Guidelines for the Management of Symptomatic Sexually Transmitted Infections [Internet]. 2021. p. 216. Available from: https://pubmed.ncbi. nlm.nih.gov/34370424/

[54] Kong FYS, Tabrizi SN, Fairley CK, Vodstrcil LA, Huston WM, Chen M, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 2014;**70**(5):1290-1297

[55] Páez-Canro C, Alzate JP, Gonzalez LM, Rubio‐Romero JA, Lethaby A, Gaitan HG. Antibiotics for treating urogenital *Chlamydia trachomatis* infection in men and nonpregnant women. Cochrane Database of Systematic Reviews. [Internet]. 2019 Jan 25 [cited 2022 Nov 28];**2019**(3).

Available from: http://doi.wiley. com/10.1002/14651858.CD010871.pub2

[56] Lau A, Kong FYS, Fairley CK, Templeton DJ, Amin J, Phillips S, et al. Azithromycin or doxycycline for asymptomatic rectal *Chlamydia trachomatis*. The New England Journal of Medicine. 2021;**384**(25):2418-2427

[57] Dombrowski JC, Wierzbicki MR, Newman LM, Powell JA, Miller A, Dithmer D, et al. Doxycycline versus azithromycin for the treatment of rectal chlamydia in men who have sex with men: A randomized controlled trial. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 2021;**73**(5):824-831

[58] Khosropour CM, Dombrowski JC, Barbee LA, Manhart LE, Golden MR. Comparing azithromycin and doxycycline for the treatment of rectal chlamydial infection: A retrospective cohort study. Sexually Transmitted Diseases. 2014;**41**(2):79-85

[59] Dukers-Muijrers NHTM, Wolffs PFG, De Vries H, Götz HM, Heijman T, Bruisten S, et al. Treatment effectiveness of azithromycin and doxycycline in uncomplicated rectal and vaginal *Chlamydia trachomatis* infections in women: A multicenter observational study (FemCure). Clinical Infectious Diseases. 2019;**69**(11):1946-1954. [Internet]. DOI: 10.1093/cid/ciz050

[60] Manavi K, Hettiarachchi N, Hodson J. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection. International journal of STD & AIDS. 2016;**27**(14):1303-1308

[61] Dukers-Muijrers NHTM, Schachter J, van Liere GAFS, Wolffs PFG, Hoebe CJPA. What is needed to guide testing for anorectal and pharyngeal

*Chlamydia trachomatis* and *Neisseria gonorrhoeae* in women and men? Evidence and opinion. BMC Infectious Diseases. [Internet] 2015;**15**(1):533. DOI: 10.1186/s12879-015-1280-6

[62] Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2005;**41**(1):67-74

[63] Bradley MG, Hobson D, Lee N, Tait IA, Rees E. Chlamydial infections of the urethra in women. Genitourinary Medicine. 1985;**61**(6):371-375

[64] Sarier M, Kukul E. Classification of non-gonococcal urethritis: A review. International Urology and Nephrology. 2019;**51**(6):901-907. [Internet]. DOI: 10.1007/s11255-019-02140-2

[65] Urethritis and Cervicitis - STI Treatment Guidelines [Internet]. [cited 2022 Nov 27]. Available from: https:// www.cdc.gov/std/treatment-guidelines/ urethritis-and-cervicitis.htm

[66] Moi H, Blee K, Horner PJ. Management of non-gonococcal urethritis. BMC Infectious Diseases. 2015;**15**:294

[67] Marcus JL, Kohn RP, Barry PM, Philip SS, Bernstein KT. *Chlamydia trachomatis* and *Neisseria gonorrhoeae* transmission from the female oropharynx to the male urethra. Sexually Transmitted Diseases. 2011;**38**(5):372-373

[68] Bernstein KT, Stephens SC, Barry PM, Kohn R, Philip SS, Liska S, et al. *Chlamydia trachomatis* and *Neisseria gonorrhoeae* transmission from the oropharynx to the urethra among men

### *Treatment of Chlamydial Infections DOI: http://dx.doi.org/10.5772/intechopen.109648*

who have sex with men. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2009;**49**(12):1793-1797

[69] Trojian TH, Lishnak TS, Heiman D. Epididymitis and orchitis: An overview. American Family Physician. 2009;**79**(7):583-587

[70] Scieux C, Barnes R, Bianchi A, Casin I, Morel P, Perol Y. Lymphogranuloma Venereum: 27 cases in Paris. The Journal of Infectious Diseases. 1989;**160**(4):662-668. [Internet]. DOI: 10.1093/infdis/160.4.662

[71] Koper NE, van der Sande MA, Gotz HM, Koedijk FD, on behalf of the Dutch STI clinics C. Lymphogranuloma venereum among men who have sex with men in the Netherlands: Regional differences in testing rates lead to underestimation of the incidence, 2006-2012. Eurosurveillance [Internet]. Aug 2013;**18**(34):2006-2012. Available from: https://www.eurosurveillance. org/content/10.2807/1560-7917. ES2013.18.34.20561

[72] Kohlhoff SA, Hammerschlag MR. Treatment of chlamydial infections: 2014 update. Expert Opinion on Pharmacotherapy. 2015;**16**(2):205-212

[73] Nwokolo NC, Dragovic B, Patel S, Tong CW, Barker G, Radcliffe K. 2015 UK national guideline for the management of infection with *Chlamydia trachomatis*. International Journal of STD and AIDS. 2016;**27**(4):251-267

[74] Chlamydia and LGV guide: Treatment and follow-up - Canada.ca [Internet]. [cited 2022 Dec 5]. Available from: https://www.canada.ca/en/publichealth/services/infectious-diseases/ sexual-health-sexually-transmittedinfections/canadian-guidelines/ chlamydia-lgv/treatment-follow-up.html [75] James G. H. Dinulos. Sexually transmitted bacterial infections. Habif's Clinical Dermatology. 2020;**1**:376-412

[76] Fan H, Gilbert R, O'Callaghan F, Li L. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: Population based cohort study. BMJ (Clinical research ed). 2020;**368**:m331

[77] Op de Coul ELM, Peek D, van Weert YWM, Morré SA, Rours I, Hukkelhoven C, et al. *Chlamydia trachomatis*, *Neisseria gonorrhoea*, and *Trichomonas vaginalis* infections among pregnant women and male partners in Dutch midwifery practices: Prevalence, risk factors, and perinatal outcomes. Reproductive Health. 2021;**18**(1):132. [Internet]. DOI: 10.1186/ s12978-021-01179-8

[78] Beem MO, Saxon E, Tipple MA. Treatment of chlamydial pneumonia of infancy. Pediatrics. 1979;**63**(2):198-203

[79] Kvien TK, Gaston JSH, Bardin T, Butrimiene I, Dijkmans BAC, Leirisalo-Repo M, et al. Three month treatment of reactive arthritis with azithromycin: A EULAR double blind, placebo controlled study. Annals of the Rheumatic Diseases. 2004;**63**(9):1113-1119

[80] Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Möttönen T, Hakola M, Korpela M, et al. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Annals of the Rheumatic Diseases. 2003;**62**(9):880-884

[81] *Chlamydia pneumoniae*: Clinical Features and Complications | CDC [Internet]. [cited 2022 Dec 7]. Available from: https://www.cdc.gov/pneumonia/ atypical/cpneumoniae/hcp/clinical.html

[82] Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: A metaanalysis. The Annals of Family Medicine. 2016;**14**(6):552 LP-552566 [Internet]. Available from: http://www.annfammed. org/content/14/6/552.abstract

[83] Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, et al. Etiology of communityacquired pneumonia in hospitalized patients in northern Israel. The Israel Medical Association journal : IMAJ. 2010;**12**(8):477-482

[84] Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. American Journal of Respiratory and Critical Care Medicine. 2019;**200**(7):E45-E67

[85] Shim JY. Current perspectives on atypical pneumonia in children. Clin Exp Pediatr. 2020;**63**(12):469-476. [Internet]. DOI: 10.3345/cep.2019.00360

[86] Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. The Pediatric Infectious Disease Journal. 1998;**17**(10):865-871

[87] Roblin PM, Hammerschlag MR. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of chlamydia pneumoniae from adults and children with communityacquired pneumonia. Antimicrobial Agents and Chemotherapy. 1998;**42**(1):194-196

[88] Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of

clarithromycin vs. erythromycin ethylsuccinate. The Pediatric Infectious Disease Journal. 1995;**14**(6):471-477

[89] Hammerschlag MR, Roblin PM. Microbiologic efficacy of moxifloxacin for the treatment of communityacquired pneumonia due to chlamydia pneumoniae. International Journal of Antimicrobial Agents. 2000;**15**(2):149-152

[90] Hammerschlag MR, Roblin PM. Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy. United States. 2000;**44**:1409

[91] Roblin PM, Montalban G, Hammerschlag MR. Susceptibilities to clarithromycin and erythromycin of isolates of chlamydia pneumoniae from children with pneumonia. Antimicrobial Agents and Chemotherapy. 1994;**38**(7):1588-1589

[92] el Moussaoui R, de Borgie CAJM, van den Broek P, Hustinx WN, Bresser P, van den Berk GEL, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: Randomised, double blind study. BMJ (Clinical research ed). 2006;**332**(7554):1355

[93] Tansarli GS, Eleftherios M. Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults. Antimicrobial Agents and Chemotherapy [Internet]. 27 Aug 2018;**62**(9):e00635-e00618. DOI: 10.1128/AAC.00635-18

[94] Same RG, Amoah J, Hsu AJ, Hersh AL, Sklansky DJ, Cosgrove SE, et al. The Association of Antibiotic Duration with successful treatment of
